Agios Pharmaceuticals Inc (AGIO) - Financial and Strategic SWOT Analysis Review

  • ID: 4285244
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • Agios Pharmaceuticals Inc
1 of 4
Summary

Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that discovers and develops investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s pipeline products comprise AG-221, an isocitrate dehydrogenase 2 mutant inhibitor; AG-120, an IDH1 mutant inhibitor; and AG-881, a pan-IDH mutant inhibitor intended for the treatment of hematologic malignancies and solid tumors. It also develops AG-348 and AG-519, a potent activator intended for the treatment of patients with pyruvate kinase deficiency. The company has collaboration with biotech companies to enhance its product candidates. Agios is headquartered in Cambridge, Massachusetts, the US.

Agios Pharmaceuticals Inc Key Recent Developments

Feb 14, 2018: Agios Reports Fourth Quarter and Full Year 2017 Financial Results
Jan 08, 2018: Agios Outlines Key 2018 Priorities Expanding Clinical and Research Programs to Drive Long Term Value
Dec 05, 2017: Agios Appoints Jacqualyn Fouse, Ph.D., to the Board of Directors
Nov 01, 2017: Agios Reports Third Quarter 2017 Financial Results
Aug 08, 2017: Agios Reports Second Quarter 2017 Financial Results

This comprehensive SWOT profile of Agios Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Agios Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Agios Pharmaceuticals Inc - Key Information
  • Agios Pharmaceuticals Inc - Overview
  • Agios Pharmaceuticals Inc - Key Employees
  • Agios Pharmaceuticals Inc - Key Employee Biographies
  • Agios Pharmaceuticals Inc - Key Operational Heads
  • Agios Pharmaceuticals Inc - Major Products and Services
  • Agios Pharmaceuticals Inc - History
  • Agios Pharmaceuticals Inc - Company Statement
  • Agios Pharmaceuticals Inc - Locations And Subsidiaries
  • Agios Pharmaceuticals Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Agios Pharmaceuticals Inc - Business Description
  • Agios Pharmaceuticals Inc - Corporate Strategy
  • Agios Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Agios Pharmaceuticals Inc - Strengths
  • Agios Pharmaceuticals Inc - Weaknesses
  • Agios Pharmaceuticals Inc - Opportunities
  • Agios Pharmaceuticals Inc - Threats
  • Agios Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Agios Pharmaceuticals Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Agios Pharmaceuticals Inc, Key Information
  • Agios Pharmaceuticals Inc, Key Ratios
  • Agios Pharmaceuticals Inc, Share Data
  • Agios Pharmaceuticals Inc, Major Products and Services
  • Agios Pharmaceuticals Inc, History
  • Agios Pharmaceuticals Inc, Key Employees
  • Agios Pharmaceuticals Inc, Key Employee Biographies
  • Agios Pharmaceuticals Inc, Key Operational Heads
  • Agios Pharmaceuticals Inc, Other Locations
  • Agios Pharmaceuticals Inc, Subsidiaries
  • Agios Pharmaceuticals Inc, Key Manufacturing facilities
  • Agios Pharmaceuticals Inc, Key Competitors
  • Agios Pharmaceuticals Inc, SWOT Analysis
  • Agios Pharmaceuticals Inc, Ratios based on current share price
  • Agios Pharmaceuticals Inc, Annual Ratios
  • Agios Pharmaceuticals Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Agios Pharmaceuticals Inc, Performance Chart
  • Agios Pharmaceuticals Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll